(相關資料圖)
CFi.CN訊：瑞康醫藥（股票代碼：002589）公布2025年半年度報告摘要。
本報告期上年同期本報告期比上年同期增減調整前調整后調整后營業收入（元）3,543,520,195.094,031,665,203.804,031,665,203.80-12.11%歸屬于上市公司股東的凈利潤（元）18,166,445.2831,025,324.7426,852,518.23-32.35%歸屬于上市公司股東的扣除非經常性損益的凈利潤（元）2,899,545.506,207,108.972,034,130.0242.54%經營活動產生的現金流量凈額（元）67,886,098.549,333,575.169,146,646.10642.20%基本每股收益（元/股）0.01210.02060.0178-32.02%稀釋每股收益（元/股）0.01210.02060.0178-32.02%加權平均凈資產收益率0.33%0.57%0.49%-0.16%本報告期末上年度末本報告期末比上年度末增減調整前調整后調整后總資產（元）17,288,636,016.5416,012,320,005.0216,037,471,948.367.80%歸屬于上市公司股東的凈資產（元）5,355,003,490.145,537,791,736.875,548,487,656.81-3.49%
